healthgevity bpc-157 + KPV + P – TrustScore® 8.3/10 bpc 157 healthgevity Healthgevity

Studies involving intravenous AOD-9604 use in humans report a half-life of 3min

The most commonly reported side effects are mild and transient: injection site redness or minor bruising, transient fatigue in the first one to two weeks, and occasionally mild headache following the first few injections, a pattern sometimes attributed to the acute shift in cellular energy metabolism as AMPK pathways are upregulated [3]

If not, this is your wake-up call

Day 30 onward: Transition to BPC-157 Delay Pro (slow-release for continued repair and maintenance)

The conversion of homocysteine to methionine reduces the potential for damage because the reaction results in the formation of the super-antioxidant glutathione